Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Andrew Hill Investment Advisors Inc.

Andrew Hill Investment Advisors Inc. lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 36.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,761 shares of the medical equipment provider's stock after selling 2,730 shares during the quarter. Intuitive Surgical comprises approximately 2.3% of Andrew Hill Investment Advisors Inc.'s investment portfolio, making the stock its 19th biggest holding. Andrew Hill Investment Advisors Inc.'s holdings in Intuitive Surgical were worth $2,358,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. raised its stake in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Castleark Management LLC lifted its stake in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after acquiring an additional 2,990 shares during the last quarter. Truist Financial Corp increased its position in Intuitive Surgical by 3.0% during the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after buying an additional 7,298 shares during the last quarter. Finally, Global X Japan Co. Ltd. boosted its position in Intuitive Surgical by 9.8% during the fourth quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider's stock worth $24,161,000 after purchasing an additional 4,140 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

ISRG stock traded up $6.11 during trading on Wednesday, hitting $557.96. The stock had a trading volume of 493,952 shares, compared to its average volume of 1,642,924. The company's 50-day moving average price is $518.20 and its two-hundred day moving average price is $538.82. The stock has a market capitalization of $199.98 billion, a P/E ratio of 87.05, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a twelve month low of $397.47 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period last year, the business earned $1.50 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,286 shares of company stock worth $12,594,546. 0.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ISRG. Royal Bank of Canada lowered their target price on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Piper Sandler reduced their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Robert W. Baird lowered their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.